Common use of Multiple Sclerosis Clause in Contracts

Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested by a neurologist. The illness must be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, as well as by MRI results. In order to confirm the diagnosis, the Insured/Insured Person must display neurological anomalies that have endured for an ongoing period of at least six (6) months, or must have had at least two (2) clinically documented episodes with an interval of at least one (1) month in between, or at least one clinically documented episode together with characteristic findings in the cerebrospinal fluid, as well as specific brain injuries detected by the MRI.

Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested by a specialist (preferably by a neurologist). The illness must disease has to be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, functions as well as by typical MRI resultsfindings. In order to confirm For proving the diagnosis, diagnosis the Insured/Insured Person must display either exhibit neurological anomalies abnormalities that have endured existed for an ongoing a continuous period of at least six (6) months, 6 months or must have had at least two (2) clinically documented episodes with an interval of at least one (1) month in between, apart or must have had at least one clinically documented episode together with characteristic findings in the cerebrospinal fluid, fluid as well as specific brain injuries detected by the MRIcerebral MRI lesions.

Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested multiple sclerosis by a Specialist acceptable to the Company (preferably by a neurologist). The illness must disease has to be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, functions as well as by typical MRI resultsfindings. In order to confirm For proving the diagnosis, diagnosis the Insured/Insured Person must display either exhibit neurological anomalies abnormalities that have endured existed for an ongoing a continuous period of at least six (6) months, months or must have had at least two (2) clinically documented episodes with an interval of at least one (1) month in between, apart or must have had at least one (1) clinically documented episode together with characteristic findings in the cerebrospinal fluid, fluid as well as specific brain injuries detected by the MRIcerebral MRI lesions.

Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested by a neurologist. The illness must be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, as well as by MRI results. In order to confirm the diagnosis, the Insured/Insured Person must display neurological anomalies that have endured for an ongoing period of at least six (6) months, or must have had at least two (2) clinically documented episodes with an interval of at least one one (1) month in between, or at least one clinically documented episode together with characteristic findings in the cerebrospinal fluid, as well as specific brain injuries detected by the MRI.

Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested multiple sclerosis by a Specialist acceptable to the Company (preferably by a neurologist). The illness must disease has to be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, functions as well as by typical MRI resultsfindings. In order to confirm For proving the diagnosis, diagnosis the Insured/Insured Person insured must display either exhibit neurological anomalies abnormalities that have endured existed for an ongoing a continuous period of at least six (6) months, months or must have had at least two (2) clinically documented episodes with an interval of at least one (1) month in between, apart or must have had at least one (1) clinically documented episode together with characteristic findings in the cerebrospinal fluid, fluid as well as specific brain injuries detected by the MRIcerebral MRI lesions.